Comparing pain relief methods after hip surgery
Comparison of Postoperative Analgesic Efficacy of Suprainguinal Fascia Iliaca Block (SFIB) and Pericapsular Nerve Group (PENG) Block With Lateral Femoral Cutaneous Nerve (LFCN) Block in Patients Undergoing Total Hip Arthroplasty
This study is testing two different pain relief methods after hip surgery to see which one helps patients feel better and recover more easily.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 48 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | Hacettepe University Academic / other |
| Locations | 1 site (Ankara) |
| Trial ID | NCT06844162 on ClinicalTrials.gov |
What this trial studies
This observational study aims to compare the effectiveness of two pain relief techniques, the suprainguinal fascia iliaca block (SFIB) and the pericapsular nerve group (PENG) block, alongside the lateral femoral cutaneous nerve (LFCN) block, in patients undergoing total hip arthroplasty. A total of 48 patients will be monitored for postoperative pain levels, opioid consumption, motor strength, and their ability to engage in physiotherapy. The study will also track any complications related to the nerve blocks or opioid use during recovery.
Who should consider this trial
Good fit: Ideal candidates are patients scheduled for primary total hip arthroplasty due to coxarthrosis.
Not a fit: Patients with a history of neuropathy, renal or hepatic insufficiency, coagulopathy, allergies to local anesthetics, prior inguinal surgery on the same side, or impaired mental status may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management strategies for patients undergoing hip surgery, potentially reducing opioid use.
How similar studies have performed: Other studies have shown promising results with similar nerve block techniques for postoperative analgesia, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who are scheduled to undergo primary total hip arthroplasty with a diagnosis of coxarthosis Exclusion Criteria: * Patients who have a history of neuropathy, patients with renal and hepatic insufficiency, patients with known coagulopathy, patients with a history of allergy to local anesthetics, patients with a history of inguinal surgery on the same side and patients with impaired mental status
Where this trial is running
Ankara
- Hacettepe University Hospitals — Ankara, Turkey (Recruiting)
Study contacts
- Study coordinator: Güneş Çelebioğlu
- Email: gunescel@hotmail.com
- Phone: +905366223440
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.